NRACX
Price
$48.47
Change
-$0.09 (-0.19%)
Updated
Aug 7 closing price
Net Assets
1.84B
VSTSX
Price
$298.03
Change
-$0.27 (-0.09%)
Updated
Aug 7 closing price
Net Assets
1.91T
Interact to see
Advertisement

NRACX vs VSTSX

Header iconNRACX vs VSTSX Comparison
Open Charts NRACX vs VSTSXBanner chart's image
Neuberger Berman Quality Equity C
Price$48.47
Change-$0.09 (-0.19%)
VolumeN/A
Net Assets1.84B
Vanguard Total Stock Mkt Idx Instl Sel
Price$298.03
Change-$0.27 (-0.09%)
VolumeN/A
Net Assets1.91T
NRACX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NRACX vs. VSTSX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRACX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. NRACX (1.84B). VSTSX pays higher dividends than NRACX: VSTSX (1.20) vs NRACX (0.00). NRACX was incepted earlier than VSTSX: NRACX (16 years) vs VSTSX (9 years). NRACX (1.82) is less costly to investors than VSTSX (0.01). NRACX is a more actively managed with annual turnover of: 8.00 vs. VSTSX (2.00). NRACX has a lower initial minimum investment than VSTSX: NRACX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.80 vs. NRACX (12.04). VSTSX return over 5 years is better than : 84.04 vs. NRACX (28.33).
NRACXVSTSXNRACX / VSTSX
Total Expense Ratio1.820.0118,200%
Annual Report Gross Expense Ratio1.820.0118,200%
Fund Existence16 years9 years-
Gain YTD4.2287.46857%
Front LoadN/AN/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.84B1.91T0%
Annual Yield % from dividends0.001.20-
Returns for 1 year12.0421.8055%
Returns for 3 years21.0150.2742%
Returns for 5 years28.3384.0434%
Returns for 10 years25.79N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOLN3.660.18
+5.32%
Molecular Partners AG
LYRA6.890.11
+1.62%
Lyra Therapeutics Inc
AACT11.39-0.02
-0.18%
Ares Acquisition Corp
IEX158.53-1.19
-0.75%
IDEX Corp
HCM16.31-1.61
-9.01%
HUTCHMED (China) Limited